BNT162b2 Vaccination in People Over 80 Years of Age Induces Strong Humoral Immune Responses with Cross Neutralisation of P.1 Brazilian Variant by Helen Marie Parry, Gokhan Tut, Sian Faustini, Christine Stephens, Philip Saunders, Christopher Bentley, Katherine Hilyard, Kevin Brown, Gayatri Amirthalingam, Sue Charlton, Stephanie Leung, Emily Chiplin, Naomi S. Coombes, Kevin R. Bewley, Elizabeth J. Penn, Cathy Rowe, Ashley Otter, Rosie Watts, Silvia D’Arcangelo, Bassam Hallis, Andrew Makin, Alex G. Richter, Jianmin Zuo, Paul Moss : : SSRN

[Pfizer] BNT162b2 #Vaccination in People Over 80 Years of Age Induces Strong Humoral Immune Responses with Cross Neutralisation of P.1 Brazilian Variant
▻https://papers.ssrn.com/sol3/papers.cfm?abstract_id=3816840

#covid-19

... although neutralisation titres were reduced 14-fold against the P.1 variant first discovered in Brazil they remained largely effective.

Interpretation: These data demonstrate that the mRNA vaccine platform delivers strong humoral immunity in people up to 96 years of age and retains broad efficacy against the P.1 Variant of Concern.

#variants